The pharmaceutical industry looks very little as it did even a decade ago. Not only has the focus shifted from the development of blockbusters to drugs aimed at indications for smaller patient populations, the majority of... read more

With considerable room for growth in emerging markets, the surge in biopharmaceutical drug development and approvals, as well as merger and acquisition activities that are helping to further existing expertise, has left ... read more

Outsourcing companies pursuing an integrated services model aim to facilitate drug development and commercialization for drug sponsors by enabling them to work with a single partner for activities that often require ... read more